John Henderson
Chairman bei CYTOKINETICS, INCORPORATED
Vermögen: 2 Mio $ am 31.03.2024
Profil
Dr. John T.
Henderson, MD, is a Chairman at Cytokinetics, Inc. Dr. Henderson was previously employed as an Independent Director by Myrexis, Inc., an Independent Director by Myriad Genetics, Inc., a President by Futurepharm LLC, a Chairman by Asmacure Ltée, a Non-Executive Director by Inveresk Research Group, Inc., a Chief Development Officer by NeuroVia, Inc., a VP-Europe, US & International Pharmaceuticals by Pfizer Inc., and a Vice President by Pfizer Pharmaceuticals, Inc. He received his undergraduate degree from The University of Edinburgh and a doctorate degree from The University of Edinburgh.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.04.2024 | 32 153 ( 0,03% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von John Henderson
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Chairman | 08.04.2022 |
Ehemalige bekannte Positionen von John Henderson
| Unternehmen | Position | Ende |
|---|---|---|
| MYRIAD GENETICS, INC. | Chairman | 23.03.2020 |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.10.2018 |
| MYREXIS, INC. | Director/Board Member | 01.01.2013 |
| PFIZER, INC. | Corporate Officer/Principal | 01.12.2010 |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01.12.2000 |
Ausbildung von John Henderson
| The University of Edinburgh | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| MYRIAD GENETICS, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| MYREXIS, INC. | Finance |
| Private Unternehmen | 5 |
|---|---|
Inveresk Research Group, Inc.
 Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Commercial Services |
Asmacure Ltée
 Asmacure Ltée Pharmaceuticals: MajorHealth Technology Asmacure Ltée develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases. The company was founded by Yvon Cormier and Evelyne Israel-Assayag in 2002 and is headquartered in Quebec, Canada. | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
| Futurepharm LLC | |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Health Technology |
